<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Bone marrow monocytic nodules (MNs) can occur in various myeloid disorders </plain></SENT>
<SENT sid="1" pm="."><plain>This retrospective review identified 21 patients with <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> who had unusual and distinct MNs </plain></SENT>
<SENT sid="2" pm="."><plain>Eight patients had <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e>); 4 had <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>); and 9 had myelodysplastic/<z:mpath ids='MPATH_512'>myeloproliferative diseases</z:mpath> </plain></SENT>
<SENT sid="3" pm="."><plain>In each case, the cells forming MNs expressed strong CD68 </plain></SENT>
<SENT sid="4" pm="."><plain>MNs appeared to persist even after aggressive chemotherapy, including conventional chemotherapy for 2 AML patients and high-dose chemotherapy preceding allogeneic bone marrow transplantation for 1 CMML patient </plain></SENT>
<SENT sid="5" pm="."><plain>Thirteen of 21 patients (62%) died, and <z:hpo ids='HP_0011009'>acute</z:hpo> leukemic transformation was the main cause of <z:hpo ids='HP_0011420'>death</z:hpo> in 3 of 8 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>The median survival of the 20 patients with appropriate follow-up was 9.8 months </plain></SENT>
<SENT sid="7" pm="."><plain>Our findings demonstrate that MNs are associated with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e>, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>, <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo>, and <z:mpath ids='MPATH_512'>myeloproliferative diseases</z:mpath> and suggest that MNs are resistant to intensive chemotherapy and patients with bone marrow MNs have a poor prognosis </plain></SENT>
</text></document>